We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
1001
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$307K 0.03%
89,878
-127,809
-59% -$394K
DYN icon
1002
Dyne Therapeutics
DYN
$4.9B
$306K 0.03%
+18,836
New +$334K
EB
1003
DELISTED
Eventbrite
EB
$306K 0.03%
+16,191
New +$284K
ENSG icon
1004
The Ensign Group
ENSG
$10.7B
$306K 0.03%
+4,088
New +$338K
KMB icon
1005
Kimberly-Clark
KMB
$36.5B
$306K 0.03%
+2,311
New +$314K
LH icon
1006
Labcorp
LH
$25.9B
$306K 0.03%
+1,266
New +$319K
MSTR icon
1007
Strategy Inc
MSTR
$38.4B
$304K 0.03%
+5,250
New +$337K
CCS icon
1008
Century Communities
CCS
$2.03B
$303K 0.03%
+4,938
New +$327K
ZSAN
1009
DELISTED
Zosano Pharma Corporation
ZSAN
$303K 0.03%
12,044
-13,094
-52% -$340K
AGO icon
1010
Assured Guaranty
AGO
$3.34B
$302K 0.03%
+6,452
New +$308K
BRKL
1011
DELISTED
Brookline Bancorp
BRKL
$302K 0.03%
+19,798
New +$287K
RAVN
1012
DELISTED
Raven Industries Inc
RAVN
$302K 0.03%
+5,238
New +$303K
CCRN
1013
DELISTED
Cross Country Healthcare
CCRN
$301K 0.03%
14,153
-13,661
-49% -$256K
COF icon
1014
Capital One
COF
$134B
$301K 0.03%
1,860
-2,032
-52% -$332K
FTEC icon
1015
Fidelity MSCI Information Technology Index ETF
FTEC
$21.3B
$300K 0.03%
2,529
TDY icon
1016
Teledyne Technologies
TDY
$32B
$300K 0.03%
698
-559
-44% -$247K
TEL icon
1017
TE Connectivity
TEL
$62.6B
$300K 0.03%
2,189
-2,135
-49% -$308K
TRIN icon
1018
Trinity Capital Inc.
TRIN
$1.71B
$300K 0.03%
+18,630
New +$284K
VRTV
1019
DELISTED
VERITIV CORPORATION
VRTV
$300K 0.03%
+3,354
New +$256K
SYBT icon
1020
Stock Yards Bancorp
SYBT
$2.6B
$299K 0.03%
+5,093
New +$261K
CPLG
1021
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$299K 0.03%
+19,315
New +$267K
KRO icon
1022
KRONOS Worldwide
KRO
$989M
$298K 0.03%
24,031
-11,411
-32% -$151K
TREE icon
1023
LendingTree
TREE
$451M
$298K 0.03%
+2,132
New +$374K
WIRE
1024
DELISTED
Encore Wire Corp
WIRE
$298K 0.03%
+3,138
New +$258K
ESTA icon
1025
Establishment Labs
ESTA
$2.28B
$297K 0.03%
4,152
-3,087
-43% -$227K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.